GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HST Global Inc (OTCPK:HSTC) » Definitions » Tax Expense

HST Global (HST Global) Tax Expense : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is HST Global Tax Expense?

HST Global's tax expense for the months ended in Dec. 2023 was $0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.


HST Global Tax Expense Historical Data

The historical data trend for HST Global's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HST Global Tax Expense Chart

HST Global Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HST Global Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

HST Global Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HST Global  (OTCPK:HSTC) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


HST Global Tax Expense Related Terms

Thank you for viewing the detailed overview of HST Global's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


HST Global (HST Global) Business Description

Traded in Other Exchanges
N/A
Address
150 Research Drive, Hampton, VA, USA, 23666
HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.
Executives
Wesley D. Tate officer: CFO and Secretary C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Ronald R. Howell director, officer: CEO and Chairman C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Pnc Labs Inc 10 percent owner 429 W PLUMB LANE, RENO NV 89509
Chun Ka Tsun director, 10 percent owner, officer: CEO TG WANASPORTS MANAGEMENT HOLDINGS, 8/F NO 211 JOHNSTON ROAD, WAN CHAI K3 00000
Chen Tsz King 10 percent owner FUGU ENTERPRISE INC, UNIT A 8TH FLOOR NO 65 SING WOOD ROAD, HAPPY VALLEY K3 00000
Li Sze Tang 10 percent owner FLAT G, 8/FL TOWER THREE, THE WATERFRONT, 1 AUSTIN ROAD WEST, TST K3 00000
Andre E Todd director 746 HILLGIRT CIRCLE, OAKLAND CA 94610
Aaron Etra director 1350 AVE OF AMERICAS, 29TH FLOOR, NEW YORK NY 10019
Communications Holding Corp 10 percent owner
Alan Lew director, 10 percent owner, officer: President 2 DOGWOOD DR, SCARSDALE NY 10583

HST Global (HST Global) Headlines